Cargando…

Distribution of Embryonic Stem Cell-Derived Mesenchymal Stem Cells after Intravenous Infusion in Hypoxic–Ischemic Encephalopathy

Systemic administration of mesenchymal stem cells (MSCs) has been reported to improve neurological function in brain damage, including hypoxic–ischemic encephalopathy (HIE), though the action mechanisms have not been fully elucidated. In this study, the cells were tracked live using a Pearl Trilogy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Su Hyun, Choung, Jin Seung, Kim, Jong Moon, Kim, Hyunjin, Kim, MinYoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861288/ https://www.ncbi.nlm.nih.gov/pubmed/36676176 http://dx.doi.org/10.3390/life13010227

Ejemplares similares

Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy
por: Gonzales-Portillo, Gabriel S., et al.
Publicado: (2014)

Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy
por: Park, Won Soon, et al.
Publicado: (2015)

Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study
por: Kabatas, Serdar, et al.
Publicado: (2021)

Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy
por: Kabataş, Serdar, et al.
Publicado: (2021)

Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy
por: Ahn, So Yoon, et al.
Publicado: (2018)

Thrombin Preconditioning Enhances Therapeutic Efficacy of Human Wharton’s Jelly–Derived Mesenchymal Stem Cells in Severe Neonatal Hypoxic Ischemic Encephalopathy
por: Kim, Young Eun, et al.
Publicado: (2019)

Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study
por: Kabataş, Serdar, et al.
Publicado: (2018)

Optimal Hypoxic Preconditioning of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells (hES-MSCs) and Their Characteristics
por: Lee, Seung Min, et al.
Publicado: (2021)

Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
por: Serrenho, Inês, et al.
Publicado: (2021)

Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain
por: Hawkins, Kate E., et al.
Publicado: (2018)

Neuroprotective effects of ginsenoside Rg1-induced neural stem cell transplantation on hypoxic-ischemic encephalopathy
por: Li, Ying-bo, et al.
Publicado: (2015)

Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011)

Preterm Hypoxic–Ischemic Encephalopathy
por: Gopagondanahalli, Krishna Revanna, et al.
Publicado: (2016)

Measurement of thalamus and cortical damages in hypoxic ischemic encephalopathy
por: Sohn, GyeongMo, et al.
Publicado: (2023)

Cell-based treatment for perinatal hypoxic-ischemic encephalopathy
por: Park, You Jeong, et al.
Publicado: (2021)

Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy
por: Wang, Lin, et al.
Publicado: (2014)

Inflammatory responses in hypoxic ischemic encephalopathy
por: Liu, Fudong, et al.
Publicado: (2013)

Biomarkers of Hypoxic-Ischemic Encephalopathy in Newborns
por: Douglas-Escobar, Martha, et al.
Publicado: (2012)

Molecular chaperones and hypoxic-ischemic encephalopathy
por: Hua, Cong, et al.
Publicado: (2017)

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
por: Eggenhofer, E., et al.
Publicado: (2012)

BDNF-Overexpressing Engineered Mesenchymal Stem Cells Enhances Their Therapeutic Efficacy against Severe Neonatal Hypoxic Ischemic Brain Injury
por: Ahn, So Yoon, et al.
Publicado: (2021)

Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat
por: Sugiyama, Yuichiro, et al.
Publicado: (2018)

Role of the epithelial–mesenchymal transition and its effects on embryonic stem cells
por: Kim, Ye-Seul, et al.
Publicado: (2014)

Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy
por: Choi, Joo-Wan, et al.
Publicado: (2022)

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
por: Taniguchi, Hidetoshi, et al.
Publicado: (2008)

Impact of Seizure Burden in Hypoxic Ischemic Encephalopathy
por: Pardo, Andrea C.
Publicado: (2015)

Language in Children with Neonatal Hypoxic-Ischemic Encephalopathy
por: Martinez, Chenia, et al.
Publicado: (2014)

Delayed cortical blindness in hypoxic-ischemic encephalopathy
por: Lee, Sang Won, et al.
Publicado: (2018)

The Function of the NMDA Receptor in Hypoxic-Ischemic Encephalopathy
por: Zhang, Xiaotong, et al.
Publicado: (2020)

Editorial: New perspectives of hypoxic ischemic encephalopathy
por: Satar, Mehmet, et al.
Publicado: (2023)

Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment
por: Choi, Seung-Cheol, et al.
Publicado: (2021)

Astroglial Activation by an Enriched Environment after Transplantation of Mesenchymal Stem Cells Enhances Angiogenesis after Hypoxic-Ischemic Brain Injury
por: Cho, Sung-Rae, et al.
Publicado: (2016)

Improvement of Cell Cycle Lifespan and Genetic Damage Susceptibility of Human Mesenchymal Stem Cells by Hypoxic Priming
por: Lee, Chang-Woo, et al.
Publicado: (2018)

Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy
por: Kim, John J, et al.
Publicado: (2013)

Diverse actions of cord blood cell therapy for hypoxic‐ischemic encephalopathy
por: Sato, Yoshiaki, et al.
Publicado: (2021)

2080: Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review of preclinical studies
por: Moreira, Alvaro, et al.
Publicado: (2018)

Intraperitoneal infusion of mesenchymal stem cell attenuates severity of collagen antibody induced arthritis
por: Nam, Yoojun, et al.
Publicado: (2018)

Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])
por: Bartolucci, Jorge, et al.
Publicado: (2017)

Preventing Brain Damage from Hypoxic–Ischemic Encephalopathy in Neonates: Update on Mesenchymal Stromal Cells and Umbilical Cord Blood Cells
por: Nabetani, Makoto, et al.
Publicado: (2021)

FGF-17 from Hypoxic Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Is Responsible for Maintenance of Cell Proliferation at Late Passages
por: Han, Kyu-Hyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_71268uasif3loj9ise8lommbg5